phosphatidylcholines has been researched along with cardiovascular agents in 9 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, S; Ehringer, W; Gray, L; Niu, W; Tseng, M; Zhang, F | 1 |
| Aldini, G; Carini, M; Facino, RM; Morazzoni, P; Rossoni, G | 1 |
| Doggrell, SA | 1 |
| Basser, R; Berry, C; Grégoire, J; Guertin, MC; Heinonen, TM; Ibrahim, R; Kouz, S; L'Allier, PL; Lavoie, MA; Lespérance, J; Rodés-Cabau, J; Tardif, JC | 1 |
| Fingerle, J; Mary, JL; Ohnsorg, PM; Pech, M; Rohrer, L; von Eckardstein, A | 1 |
| Belcaro, G; Cesarone, MR; Cornelli, U; Dugall, M; Feragalli, B; Hosoi, M; Luzzi, R | 1 |
| Gao, D; Han, L; Qin, J; Sun, X; Wang, J; Zhang, L | 1 |
| Deng, J; Li, WG; Ning, Q; Yu, DN; Zhou, Y | 1 |
| Bae, YS; Chelakkot, C; Ghim, J; Ryu, SH; Suh, PG | 1 |
2 review(s) available for phosphatidylcholines and cardiovascular agents
| Article | Year |
|---|---|
ETC-588 (Pfizer).
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Humans; Phosphatidylcholines; Randomized Controlled Trials as Topic | 2004 |
Accumulating insights into the role of phospholipase D2 in human diseases.
Topics: Animals; Antineoplastic Agents; Cardiovascular Agents; Gene Expression Regulation; Humans; Immune System Diseases; Immunologic Factors; Mice; Neoplasms; Nervous System Diseases; Neuroprotective Agents; Phosphatidic Acids; Phosphatidylcholines; Phospholipase A2 Inhibitors; Phospholipase D; Signal Transduction; Vascular Diseases | 2016 |
2 trial(s) available for phosphatidylcholines and cardiovascular agents
| Article | Year |
|---|---|
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
Topics: Aged; Angina, Unstable; Apolipoprotein A-I; Cardiovascular Agents; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Phosphatidylcholines; Ultrasonography, Interventional | 2007 |
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy.
Topics: Administration, Topical; Adult; Cardiovascular Agents; Diabetic Angiopathies; Escin; Female; Gels; Heparin; Humans; Male; Microcirculation; Middle Aged; Phosphatidylcholines; Registries; Treatment Outcome; Venous Insufficiency | 2011 |
5 other study(ies) available for phosphatidylcholines and cardiovascular agents
| Article | Year |
|---|---|
Enhancement of hypothermic heart preservation with fructose 1, 6-diphosphate.
Topics: Animals; Cardiovascular Agents; Cryopreservation; Fructosediphosphates; Heart; In Vitro Techniques; Lipid Bilayers; Male; Microscopy, Electron; Myocardial Reperfusion; Myocardium; Organ Preservation; Organ Size; Ovum; Oxygen Consumption; Phosphatidylcholines; Rats; Rats, Sprague-Dawley | 1999 |
Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat.
Topics: Animals; Antioxidants; Cardiovascular Agents; Drug Combinations; Ginkgo biloba; Heart; In Vitro Techniques; Ischemia; Male; Medicine, Chinese Traditional; Myocardial Reperfusion Injury; Phosphatidylcholines; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar | 2001 |
Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
Topics: Animals; Aorta; Apolipoprotein A-I; Atherosclerosis; ATP-Binding Cassette Transporters; Cardiovascular Agents; Cattle; Coronary Disease; Endothelial Cells; Gene Silencing; Humans; Kinetics; Lipoproteins, HDL; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines; Protein Binding; Protein Transport; Recombinant Proteins; RNA, Small Interfering | 2011 |
The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B.
Topics: Animals; Benzofurans; Biological Availability; Capsules; Cardiovascular Agents; Chemistry, Pharmaceutical; Cholesterol; Dogs; Glycine max; Half-Life; Liposomes; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Salvia miltiorrhiza | 2012 |
Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Capsules; Cardiovascular Agents; Cholesterol; Drug Delivery Systems; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Liposomes; Male; Particle Size; Permeability; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Sprague-Dawley | 2014 |